Thyrocare Technologies Limited

NSEI:THYROCARE Stock Report

Market Cap: ₹52.0b

Thyrocare Technologies Valuation

Is THYROCARE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of THYROCARE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: THYROCARE (₹963.15) is trading above our estimate of fair value (₹716.23)

Significantly Below Fair Value: THYROCARE is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for THYROCARE?

Key metric: As THYROCARE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for THYROCARE. This is calculated by dividing THYROCARE's market cap by their current earnings.
What is THYROCARE's PE Ratio?
PE Ratio60.8x
Earnings₹839.60m
Market Cap₹52.05b

Price to Earnings Ratio vs Peers

How does THYROCARE's PE Ratio compare to its peers?

The above table shows the PE ratio for THYROCARE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average60.7x
METROPOLIS Metropolis Healthcare
70x23.8%₹103.6b
VIJAYA Vijaya Diagnostic Centre
82.7x25.4%₹103.6b
KRSNAA Krsnaa Diagnostics
43.6x35.5%₹29.9b
526783 Dr. Agarwal's Eye Hospital
46.5xn/a₹23.5b
THYROCARE Thyrocare Technologies
60.8x26.9%₹52.0b

Price-To-Earnings vs Peers: THYROCARE is expensive based on its Price-To-Earnings Ratio (60.8x) compared to the peer average (60.7x).


Price to Earnings Ratio vs Industry

How does THYROCARE's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.79m
542918 Gian Life Care
4.9xn/aUS$2.35m
No more companies available in this PE range
THYROCARE 60.8xIndustry Avg. 41.8xNo. of Companies6PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: THYROCARE is expensive based on its Price-To-Earnings Ratio (60.8x) compared to the Indian Healthcare industry average (41.8x).


Price to Earnings Ratio vs Fair Ratio

What is THYROCARE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

THYROCARE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio60.8x
Fair PE Ratio57.9x

Price-To-Earnings vs Fair Ratio: THYROCARE is expensive based on its Price-To-Earnings Ratio (60.8x) compared to the estimated Fair Price-To-Earnings Ratio (57.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst THYROCARE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹963.15
₹1,007.50
+4.6%
3.2%₹1,040.00₹975.00n/a2
Nov ’25₹927.70
₹1,007.50
+8.6%
3.2%₹1,040.00₹975.00n/a2
Oct ’25₹828.10
₹800.00
-3.4%
3.1%₹825.00₹775.00n/a2
Sep ’25₹861.80
₹800.00
-7.2%
3.1%₹825.00₹775.00n/a2
Aug ’25₹818.00
₹800.00
-2.2%
3.1%₹825.00₹775.00n/a2
Jul ’25₹650.75
₹740.00
+13.7%
1.4%₹750.00₹730.00n/a2
Jun ’25₹612.20
₹740.00
+20.9%
1.4%₹750.00₹730.00n/a2
May ’25₹644.95
₹727.50
+12.8%
0.3%₹730.00₹725.00n/a2
Apr ’25₹607.00
₹722.50
+19.0%
0.3%₹725.00₹720.00n/a2
Mar ’25₹681.45
₹722.50
+6.0%
0.3%₹725.00₹720.00n/a2
Feb ’25₹616.55
₹730.00
+18.4%
1.4%₹740.00₹720.00n/a2
Jan ’25₹652.35
₹695.00
+6.5%
6.5%₹740.00₹650.00n/a2
Dec ’24₹566.35
₹632.50
+11.7%
2.8%₹650.00₹615.00n/a2
Nov ’24₹546.65
₹632.50
+15.7%
2.8%₹650.00₹615.00₹927.702
Oct ’24₹568.30
₹647.50
+13.9%
0.4%₹650.00₹645.00₹828.102
Sep ’24₹537.85
₹647.50
+20.4%
0.4%₹650.00₹645.00₹861.802
Aug ’24₹590.40
₹737.00
+24.8%
13.2%₹834.00₹640.00₹818.002
Jul ’24₹517.95
₹782.00
+51.0%
6.6%₹834.00₹730.00₹650.752
Jun ’24₹455.95
₹782.00
+71.5%
6.6%₹834.00₹730.00₹612.202
May ’24₹441.80
₹782.00
+77.0%
6.6%₹834.00₹730.00₹644.952
Apr ’24₹429.85
₹782.00
+81.9%
6.6%₹834.00₹730.00₹607.002
Mar ’24₹450.75
₹782.00
+73.5%
6.6%₹834.00₹730.00₹681.452
Feb ’24₹531.75
₹743.33
+39.8%
9.3%₹834.00₹666.00₹616.553
Jan ’24₹618.65
₹743.33
+20.2%
9.3%₹834.00₹666.00₹652.353
Dec ’23₹631.40
₹743.33
+17.7%
9.3%₹834.00₹666.00₹566.353
Nov ’23₹644.20
₹785.33
+21.9%
16.1%₹960.00₹666.00₹546.653

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies